Xilio Therapeutics hires Yariv Houvras as CMO — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Xilio Therapeutics hired Yariv Houvras as its new chief medical officer, as flagged in STAT's regular "comings and goings" personnel feature.
- Yariv Houvras previously served as senior vice president of clinical and translational development at Tubulis before moving into the CMO role at Xilio.
Why it matters: Xilio Therapeutics filled its top medical officer seat with a candidate bringing direct experience running clinical and translational development at another clinical-stage biotech. The lateral move between two pipeline-stage companies comes as Xilio continues advancing its clinical-stage programs.
Ask SkimNews